{"ORPHApacket":[{"ORPHApacketID":"268173","date":"2019-12-06 01:55:38","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"268173","Name":[{"lang":"en","label":"Intermittent maple syrup urine disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_268173","DisorderType":[{"Name":[{"lang":"en","label":"Clinical subtype"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377796"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Maple syrup urine disease"}],"ORPHA":"511","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_511"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Intermittent maple syrup urine disease (intermittent MSUD) is a mild form of MSUD (see this term) where patients (when well) are asymptomatic with normal levels of branched-chain amino acids (BCAAs) but with catabolic stress are at risk of acute decompensation with ketoacidosis, which can lead to cerebral edema and coma if untreated."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"248600","DisorderMappingRelation":[{"id":"21534","Name":[{"lang":"en","label":"NTBT (narrower term maps to a broader term)"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"3","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]},{"Name":[{"lang":"en","label":"Infancy"}]},{"Name":[{"lang":"en","label":"Neonatal"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"Intermittent BCKD deficiency"},{"lang":"en","label":"Intermittent MSUD"},{"lang":"en","label":"Intermittent branched-chain alpha-ketoacid dehydrogenase deficiency"}]}]}]}